Literature DB >> 233166

Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis.

M Pittman.   

Abstract

The nature of the pathogenesis and of the prolonged immunity of whooping cough has not been clearly defined. The literature of Bordetella pertussis indicated that only the antigen that induces histamine sensitization, lymphocytosis, and other biological reactions in mice is the cause of the harmful effects and prolonged immunity of whooping cough. This antigen has the general characteristics of bacterial protein exotoxins that cause the harmful effects of infectious diseases such as diphtheria and tetanus. It is proposed that this antigen, which is histamine-sensitizing, lymphocyte-leukocyte-promoting, and islets-activating (HSF-LPF-IAP), be designated pertussis toxin. Agglutinogen, hemagglutinin, and heat-labile (at 56 C) and heat-stable (at 100 C) toxins are no doubt interrelated with the immunologic and/or toxic reactions of whooping cough. It appears that the first defense against the disease is the antibody that prevents adhesion of the bacteria to the cilia of the respiratory epithelium and that the second defense is the antitoxin against pertussis toxin (HSF-LPF-IAP).

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 233166     DOI: 10.1093/clinids/1.3.401

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  75 in total

1.  Antibacterial agents and release of periplasmic pertussis toxin from Bordetella pertussis.

Authors:  K A Craig-Mylius; A A Weiss
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

2.  Bordetella pertussis virulence factors affect phagocytosis by human neutrophils.

Authors:  C L Weingart; A A Weiss
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

3.  Suppression of serum antibody responses by pertussis toxin after respiratory tract colonization by Bordetella pertussis and identification of an immunodominant lipoprotein.

Authors:  Nicholas H Carbonetti; Galina V Artamonova; Charlotte Andreasen; Edward Dudley; R Michael Mays; Zoe E V Worthington
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

4.  Analysis of bvgR expression in Bordetella pertussis.

Authors:  Tod J Merkel; Philip E Boucher; Scott Stibitz; Vanessa K Grippe
Journal:  J Bacteriol       Date:  2003-12       Impact factor: 3.490

5.  Activation of the vrg6 promoter of Bordetella pertussis by RisA.

Authors:  Tadhg O Cróinín; Vanessa K Grippe; Tod J Merkel
Journal:  J Bacteriol       Date:  2005-03       Impact factor: 3.490

6.  Immunoblot analysis of humoral immune responses following infection with Bordetella pertussis or immunization with diphtheria-tetanus-pertussis vaccine.

Authors:  S C Redd; H S Rumschlag; R J Biellik; G N Sanden; C B Reimer; M L Cohen
Journal:  J Clin Microbiol       Date:  1988-07       Impact factor: 5.948

7.  Detection of Bordetella pertussis by determination of adenylate cyclase activity.

Authors:  C H Wirsing von Koenig; A Tacken; E L Hewlett
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-07       Impact factor: 3.267

8.  Pertussis holotoxoid formed in vitro with a genetically deactivated S1 subunit.

Authors:  T D Bartley; D W Whiteley; V L Mar; D L Burns; W N Burnette
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

9.  Antibody-mediated neutralization of pertussis toxin-induced mitogenicity of human peripheral blood mononuclear cells.

Authors:  Scott H Millen; David I Bernstein; Beverly Connelly; Joel I Ward; Swei-Ju Chang; Alison A Weiss
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

10.  In vitro inhibition of murine macrophage migration by Bordetella pertussis lymphocytosis-promoting factor.

Authors:  B D Meade; P D Kind; J B Ewell; P P McGrath; C R Manclark
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.